Lexaria Explores Alternatives for Diabetes and Obesity Management
Lexaria explores alternatives to traditional diabetes and obesity management through its patented DehydraTECH technology, potentially enhancing oral ingestion vs. injection treatment of GLP-1 drugs. With projections showing a significant increase in the number of people living with diabetes by 2045, Lexaria's exploration of alternative treatments is timely and important.
This news matters because, with projections showing a significant increase in the number of people living with diabetes, the exploration of alternative treatments by Lexaria using DehydraTECH technology is timely and important.
